6 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Platform of Randomized Adaptive Clinical Trials in Critical IllnessRespiration Disorders, respiratory failure, respiratory system disorderRecruitingNot applicable2026-10-06NCT05440851
SDCC - Prospective Cohort Study of Chronic Renal InsufficiencyChronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorderActive, not recruitingNot stated2026-06-26NCT00304148
ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's DiseaseParkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathyActive, not recruitingNot applicable2026-03-20NCT03319485
Physical Acvitiy in PregnancyBody Weight, Female Urogenital Diseases and Pregnancy Complications, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Pregnancy in Obesity, Signs and Symptoms, Urogenital Diseases, diabetes mellitus, endocrine system disorder, gestational diabetes, glucose metabolism disease, metabolic disease, nutritional disorder, obesity disorder, overnutrition, pregnancy disorderEnrolling by invitationNot stated2026-01-21NCT07356180
Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck cancer, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinomaActive, not recruitingPhase 22025-08-03NCT04675333
Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck cancer, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinomaActive, not recruitingPhase 22025-08-01NCT04675294